ObservationalActive, not recruitingNCT07160816
Real-world insulin icodec use in type 1 diabetes
Novo Nordisk observational study following adults with type 1 diabetes newly prescribed once-weekly insulin icodec in usual clinical practice in Germany and Italy.
Primary endpoints
- Change in HbA1c from baseline to week 26
Results so far
No results posted yet.